Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Bayesian confidence propagation neural network.

Andrew Bate1

  • 1WHO Collaborating Centre for International Drug Monitoring, Uppsala Monitoring Centre, Uppsala, Sweden. andrew.bate@who-umc.org

Drug Safety
|July 3, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Global Perspective on the Evolution and Future of Pharmacovigilance: Deliverables from the 24th Annual Meeting of the International Society of Pharmacovigilance Celebrating 25 Years of Excellence.

Drug safety·2026
Same author

Reply to "A Comment about AI Methods that May Help Advance Pharmacovigilance".

Clinical pharmacology and therapeutics·2026
Same author

9<sup>th</sup> ISoP Intelligent Automation Boston Seminar: From Innovation to Impact. Building Trustworthy AI in Pharmacovigilance 4-5 December 2025 | Cambridge, USA & Virtual.

Drug safety·2026
Same author

Ontology-based Semantic Similarity Measures for Clustering Medical Concepts in Drug Safety.

AMIA ... Annual Symposium proceedings. AMIA Symposium·2026
Same author

PVLens: Enhancing Pharmacovigilance Through Automated Label Extraction.

AMIA ... Annual Symposium proceedings. AMIA Symposium·2026
Same author

Performance of the Self-Controlled Case Series for Drug Safety Signal Detection: A Multi-Database Study.

Pharmacoepidemiology and drug safety·2026
Same journal

Availability and Communication of Risk Management Strategies for Pregnancy Category X Medicines across Australian Medicine Information Sources.

Drug safety·2026
Same journal

The Bidirectionality of Lawyer Reporting Bias in Disproportionality Analysis.

Drug safety·2026
Same journal

Safety of Biologic and Targeted Synthetic Disease-Modifying Antirheumatic Drugs in Rheumatoid Arthritis: A Longitudinal Analysis.

Drug safety·2026
Same journal

Developing a Hierarchical Algorithm to Identify Pregnancies and Determine Gestational Age from Nationwide Linked Health Data in Taiwan.

Drug safety·2026
Same journal

Safety and Effectiveness of Direct Oral Anticoagulants Versus Low-Molecular-Weight Heparin for Cancer-Associated Thrombosis: A Systematic Review and Meta-analysis.

Drug safety·2026
Same journal

Analytic Misjudgment of Drug Safety Evidence and Causality: From the Prosecutor's Fallacy and Simpson's Paradox to Artificial Intelligence.

Drug safety·2026
See all related articles

Bayesian confidence propagation neural networks (BCPNN) enhance adverse drug reaction (ADR) detection. This data mining technique identifies potential drug-ADR relationships for clinical review, improving patient safety.

Area of Science:

  • Pharmacovigilance and data science
  • Computational methods in drug safety
  • Artificial intelligence in healthcare

Background:

  • Adverse drug reactions (ADRs) pose a significant public health challenge.
  • Early detection of potential drug-ADR relationships is crucial for patient safety.
  • Existing data mining techniques require continuous improvement for signal detection.

Purpose of the Study:

  • To discuss recent advances in Bayesian confidence propagation neural network (BCPNN) methods for adverse drug reaction (ADR) signal detection.
  • To highlight the application of BCPNN in large-scale databases for identifying unknown drug-ADR relationships.
  • To demonstrate the utility of data mining in enhancing drug safety surveillance.

Main Methods:

  • Utilizing a Bayesian confidence propagation neural network (BCPNN) for data mining of suspected adverse drug reactions (ADRs).

Related Experiment Videos

  • Applying recurrent neural networks to analyze cyclo-oxygenase 2 inhibitor data.
  • Employing data-mining methods for improving data quality, including duplicate report detection.
  • Extending BCPNN application to a large patient-record database (IMS Disease Analyzer).

    • Main Results:

    • Routine data mining using BCPNN has successfully identified significant drug-ADR signals since 1998.
    • Prospectively detected signals include topiramate-associated glaucoma and SSRI-associated neonatal withdrawal syndrome.
    • Analysis of cyclo-oxygenase 2 inhibitors identified patterns for rofecoxib and celecoxib.

    Conclusions:

    • BCPNN is an effective technique for large-scale pharmacovigilance and adverse drug reaction (ADR) signal detection.
    • Advances in BCPNN methods improve the identification of novel drug-ADR associations.
    • Data mining with BCPNN contributes to enhanced drug safety and data quality in healthcare databases.